Search Results 2031-2040 of 20153 for Receptor
... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...
Previous use of PLX3397 or any biologic treatment targeting Colony Stimulating Factor 1 (CSF1) or the Colony Stimulating Factor 1 Receptor (CSF1R); previous ...
Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study. Mov Disord. 2018 Aug ...
Medicines called angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) can help control blood pressure. These medicines ...
... receptor (EGFR) antibody targeted therapy due to mesenchymal epithelial transition factor (MET) amplification. Irinotecan and Cetuximab With or Without ...
Neurologist. Rochester, MN. Areas of focus: Movement disorder, Dystonia, NMDA receptor antibody encephalitis, Myelin oligodendrocyte glycoprotein antibody- ...
(open studies only). Filter this list of studies by location, status and more. Exploring the Role of B-cell Activating Factor Receptor (BAFFR)- ...
... Receptor 2 (HER2)-Positive Breast Cancer and Brain Metastases. 2017 - present. MemberMayo Clinic Women's Cancer Program. 2017 - present. Breast Committee Member ...
Memantine may block receptors (parts of nerve cells) in the brain known to contribute to a decline in cognitive function. Giving memantine may make a difference ...
... receptor blocker and a calcium channel blocker). MDRD estimated GFR > 30 mL/min to be calculated at the screening visit by available serum creatinine. Male ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!